Clinical Trial

Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 12, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Endometrial cancer (EC) is the most common gynecological malignancy in high-income countries. Prognosis and treatment are dictated by cancer histological subtype and grade coupled with surgical staging as described by Surgical International Federation of Gynecology and Obstetrics (FIGO) staging system. Surgery is the elective standard treatment and used for staging of EC. The purpose of this study is to collect images from a simultaneous PET/MRI study from which to extrapolate a preoperative, non-invasive, prognostic model.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-12-25; most recent amendment 2024-04-11.
Trial Details
NCT Number NCT04212910
Lead Sponsor IRCCS San Raffaele
Conditions Endometrium Cancer
Enrollment 101 participants
Start Date 2019-07-23
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-04-12